Getting MM literally saved my life! Let me explain:
I was diagnosed in Feb. 2018 and didn't need treatment right away. Then in Jan 2020 I was told I needed spine surgery (unrelated to MM). I had that and then had two Stem Cell Transplants-May 2020 and then in Sept. 2020. Both were 15 days each in isolation because of covid.
I've been in remission since then and I believe it's because we went aggressively at it with the tandem transplants. I do a monthly maintenance regimen with Velcade and Solumedrol and also take Revlimid 3 days per week. I have a very positive attitude and I make treatment day one that I look forward to-because it's keeping me alive!
My spine surgery was the result of the MM original diagnosis - I started doing MRI's, PET scans and Bone scans every six months and they found a benign tumor in my spinal canal and it had tripled in size between June 2018 and Dec. 2019. It was intertwined with spinal nerves and was blocking 90% of the flow of spinal fluid. In fact, when I first met the neurosurgeon at the pre-surgery appt., he was amazed I still had full movement of my arms and legs and said I was very lucky I hadn't had a massive stroke or full paralysis from the tumor because it was blocking so much fluid flow. Surgery was removing 5 inches of my spine to get the tumor out, and then putting in plates and screws to fix. I feel back to normal now but getting MM saved my life! I would have been dead from a massive stroke or would be paralyzed if not for the MRI's, Pet Scans, body scans, etc. that all found the tumor.
My belief is to find the positive in your situation-whatever it is. We're still ALIVE and we have options that many do not have!

Your Feed
Filter by
See content from
Playlist: EHA 2024
Real-World Schedule De-escalation of Teclistamab in Patients with RRMM | Carlyn Tan, MD | EHA 2024
Video details & playlist
Playlist: EHA 2024
High Response Rates With T Cell Engagers in Follicular Lymphoma | Ryan Jacobs, MD | EHA 2024
Video details & playlist
Playlist: EHA 2024
CAR-T Therapy in Patients 75+ with Relapsed/Refractory DLBCL | Pierre Bories, MD, PhD | EHA 2024
Video details & playlist
Playlist: EHA 2024
Outcomes in High-Risk Subgroups After Ibrutinib and Venetoclax for CLL | Ryan Jacobs, MD | EHA 2024
Video details & playlist
Playlist: EHA 2024
Phase 1b-2 Dose Escalation Study Sonrotoclax + Dexamethasone | Binod Dhakal, MD | EHA 2024
Video details & playlist
Playlist: EHA 2024
CARTITUDE-4 Subgroup Analysis of Functional High-Risk Patients | Luciano Costa, MD | EHA 2024
Video details & playlist
Playlist: EHA 2024
Mezigdomide, Tazemetostat, and Dex in RRMM: Results from CA057-003 Trial | Luciano Costa, MD | EHA 2024
Video details & playlist
Playlist: EHA 2024
MAJESTIC-1 Study - A Subgroup Analysis of High-risk Patients | Luciano Costa, MD | EHA2024
Video details & playlist
Playlist: EHA 2024
ASCO/EHA Myeloma Updates 2024 | Claudio Cerchione, MD | EHA 2024
Video details & playlist
Playlist: EHA 2024
The Role of Combination FDG PET Plus Whole Body MRI for Staging | Claudio Cerchione, MD | EHA 2024
Video details & playlist









